Literature DB >> 6312965

Purification of the 22000- and 20000-mol.wt. forms of human somatotropin and characterization of their binding to liver and mammary binding sites.

J Closset, J Smal, F Gomez, G Hennen.   

Abstract

Quantitative data concerning the binding of 22000-mol.wt. human somatotropin and its 20000-mol.wt. variant are described using pregnant-rabbit liver and mammary-gland receptors. The purification and the complete chemical characterization of both human somatotropin and its 20000-mol.wt. variant is also presented. Contamination of the 20000-mol.wt.-variant preparation by 22000-mol.wt. hormone was found to be 0.5% by weight as measured in radioimmunoassay using monoclonal antibody. Labelling of human somatotropin and its 20000-mol.wt. variant using the Iodogen method is described as well as the characterization of the binding to pregnant-rabbit liver and mammary-gland receptor preparations. The maximum binding capacity of the 125I-labelled human somatotropin was between 50 and 60% to liver particulate receptor, whereas that of the 20000-mol.wt. variant was 30%. The specificity of binding of both forms to rabbit hepatic and mammary-gland receptor was found to be similar for both proteins in the same system. The affinity constants and capacity were respectively 0.7 X 10(10)M-1 and 815 fmol/mg of protein for human somatotropin and 0.6 X 10(10)M-1 and 1.250 fmol/mg of protein for the 20000-mol.wt. variant. These data suggest that both proteins behave as partial agonists to the receptors studied.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312965      PMCID: PMC1152328          DOI: 10.1042/bj2140885

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  The application of 0.1 M quadrol to the microsequence of proteins and the sequence of tryptic peptides.

Authors:  A W Brauer; M N Margolies; E Haber
Journal:  Biochemistry       Date:  1975-07       Impact factor: 3.162

2.  Kinetics of gonadotropin binding by receptors of the rat testis. Analysis by a nonlinear curve-fitting method.

Authors:  J M Ketelslegers; G D Knott; K J Catt
Journal:  Biochemistry       Date:  1975-07-15       Impact factor: 3.162

3.  Studies of insulin, growth hormone and prolactin binding: ontogenesis, effects of sex and pregnancy.

Authors:  P A Kelly; B I Posner; T Tsushima; H G Friesen
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

4.  Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization.

Authors:  B I Posner; P A Kelly; R P Shiu; H G Friesen
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

5.  Radioreceptor assay for growth hormone.

Authors:  T Tsushima; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

6.  Solubilization and purification of a prolactin receptor from the rabbit mammary gland.

Authors:  R P Shiu; H G Friesen
Journal:  J Biol Chem       Date:  1974-12-25       Impact factor: 5.157

7.  Isoelectric focusing of proteins in polyacrylamide gels.

Authors:  O Vesterberg
Journal:  Biochim Biophys Acta       Date:  1972-01-26

8.  Porcine thyrotropin. Isolation and characterization of the hormone and its alpha and beta subunits.

Authors:  J Closset; G Hennen
Journal:  Eur J Biochem       Date:  1974-08-01

9.  Production of "sulphation factor" by the perfused liver.

Authors:  P McConaghey; C B Sledge
Journal:  Nature       Date:  1970-03-28       Impact factor: 49.962

10.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

View more
  2 in total

1.  Receptor-binding and down-regulatory properties of 22000-Mr human growth hormone and its natural 20000-Mr variant on IM-9 human lymphocytes.

Authors:  J Smal; J Closset; G Hennen; P de Meyts
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

2.  Sphingosine, an inhibitor of protein kinase C, suppresses the insulin-like effects of growth hormone in rat adipocytes.

Authors:  J Smal; P De Meyts
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.